DRUG INTERACTIONS IN EXPERIMENTAL HEPATIC PORPHYRIA - MODEL FOR EXACERBATION BY DRUGS OF HUMAN VARIEGATE PORPHYRIA

被引:35
作者
DEMATTEIS, F [1 ]
机构
[1] MRC, TOXICOL UNIT, BIOCHEM MECH SECT, CARSHALTON, SURREY, ENGLAND
关键词
D O I
10.1159/000459390
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:266 / 275
页数:10
相关论文
共 17 条
[2]   DRUG-INDUCED PORPHYRIN BIOSYNTHESIS .7. SPECIES, SEX, AND DEVELOPMENTAL DIFFERENCES IN GENERATION OF EXPERIMENTAL PORPHYRIA [J].
CREIGHTON, JM ;
MARKS, GS .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1972, 50 (06) :485-+
[3]  
De Matteis F, 1971, Biochem J, V124, P767
[4]  
De Matteis F., 1971, S AFR J LAB CLIN MED, V17, P126
[5]  
De Matteis F., 1972, BIOCHEM J, V130, p52p
[6]  
DEAN GEOFFREY, 1959, S AFRICAN MED JOUR, V33, P246
[8]  
DEMATTEIS F, 1967, PHARMACOL REV, V19, P523
[9]   DECREASED LIVER ACTIVITY OF PORPHYRIN-METAL CHELATASE IN HEPATIC PORPHYRIA CAUSED BY 3,5-DIETHOXYCARBONYL-1,4-DIHYDROCOLLIDINE - STUDIES IN RATS AND MICE [J].
DEMATTEIS, F ;
ABBRITTI, G ;
GIBBS, AH .
BIOCHEMICAL JOURNAL, 1973, 134 (03) :717-727
[10]  
DEMATTEIS F, 1972, BIOCHEM J, V127, P21